糖酵解减少参与血管紧张素II诱导的足细胞损伤及足突融合
该研究在体内和体外证实血管紧张素II暴露使足细胞丙酮酸激酶M2表达快速下降、糖酵解通量减少,足细胞特异性敲除丙酮酸激酶M2加重血管紧张素II诱导的肾小球和足细胞损伤、足突融合及蛋白尿;高血压肾病和糖尿病肾病患者肾活检足细胞丙酮酸激酶M2表达也降低。
要点
- 血管紧张素II在体内和体外使足细胞丙酮酸激酶M2表达快速下降、糖酵解通量减少。
- 足细胞特异性敲除丙酮酸激酶M2加重血管紧张素II诱导的肾小球和足细胞损伤、足突融合及蛋白尿。
- 糖酵解抑制伴随三磷酸腺苷缺乏、细胞骨架重塑和足细胞凋亡。
核心结论
- 血管紧张素II诱导的糖酵解受损导致足突能量供应不足,进而引起足细胞损伤。
- 糖酵解激活是足细胞损伤的潜在治疗策略。
研究设计与样本
- 研究在体内和体外观察血管紧张素II暴露对足细胞丙酮酸激酶M2表达和糖酵解通量的影响。
- 使用足细胞特异性敲除丙酮酸激酶M2的小鼠评估血管紧张素II诱导的肾小球和足细胞损伤。
- 检测高血压肾病和糖尿病肾病患者肾活检足细胞中丙酮酸激酶M2的表达。
主要发现
- 血管紧张素II在体内和体外使足细胞丙酮酸激酶M2表达快速下降、糖酵解通量减少。
- 足细胞特异性敲除丙酮酸激酶M2加重血管紧张素II诱导的肾小球和足细胞损伤、足突融合及蛋白尿。
- 糖酵解抑制伴随三磷酸腺苷缺乏、细胞骨架重塑和足细胞凋亡。
- 高血压肾病和糖尿病肾病患者肾活检足细胞中丙酮酸激酶M2表达降低。
临床怎么用
- 作者认为糖酵解激活是足细胞损伤的潜在治疗策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Activation of the renin-angiotensin system is associated with podocyte injury and has been well demonstrated as a pivotal factor in the progression of chronic kidney disease. Podocyte energy metabolism is crucial for maintaining their physiological functions. However, whether renin-angiotensin system activation promotes chronic kidney disease progression by disturbing the energy metabolism of podocytes has not been elucidated. Angiotensin II, the main active molecule of the renin-angiotensin system, plays a crucial role in chronic kidney disease initiation and progression, but its impact on podocyte metabolism remains unclear. Here, we demonstrate a rapid decrease in the expression of pyruvate kinase M2, a key glycolytic enzyme, and reduced glycolytic flux in podocytes exposed to angiotensin II in vivo and in vitro. Podocyte-specific deletion of pyruvate kinase M2 in mice aggravated angiotensin II-induced glomerular and podocyte injury with foot process effacement and proteinuria. The inhibition of glycolysis was accompanied by adenosine triphosphate deficiency, cytoskeletal remodeling and podocyte apoptosis. Mechanistically, we found that angiotensin II-induced glycolysis impairment contributed to an insufficient energy supply to the foot process, leading to podocyte injury. Additionally, pyruvate kinase M2 expression was found to be reduced in podocytes from kidney biopsies of patients with hypertensive nephropathy and diabetic kidney disease. Thus, our findings suggest that glycolysis activation is a potential therapeutic strategy for podocyte injury.
引用
- Chen Z, Zhu Z, Liang W, et al. Reduction of anaerobic glycolysis contributes to angiotensin II-induced podocyte injury with foot process effacement. Kidney Int. 2023. PMID: 36731609. doi:10.1016/j.kint.2023.01.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。